These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 18022558)

  • 21. TRAP1: a viable therapeutic target for future cancer treatments?
    Lettini G; Maddalena F; Sisinni L; Condelli V; Matassa DS; Costi MP; Simoni D; Esposito F; Landriscina M
    Expert Opin Ther Targets; 2017 Aug; 21(8):805-815. PubMed ID: 28664757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heat shock protein 90 acts as a molecular chaperone in late-phase activation of extracellular signal-regulated kinase 1/2 stimulated by oxidative stress in vascular smooth muscle cells.
    Liu DH; Yuan HY; Cao CY; Gao ZP; Zhu BY; Huang HL; Liao DF
    Acta Pharmacol Sin; 2007 Dec; 28(12):1907-13. PubMed ID: 18031603
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-proliferative activity of heat shock protein (Hsp) 90 inhibitors via beta-catenin/TCF7L2 pathway in adult T cell leukemia cells.
    Kurashina R; Ohyashiki JH; Kobayashi C; Hamamura R; Zhang Y; Hirano T; Ohyashiki K
    Cancer Lett; 2009 Oct; 284(1):62-70. PubMed ID: 19464103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rational Design of Allosteric and Selective Inhibitors of the Molecular Chaperone TRAP1.
    Sanchez-Martin C; Moroni E; Ferraro M; Laquatra C; Cannino G; Masgras I; Negro A; Quadrelli P; Rasola A; Colombo G
    Cell Rep; 2020 Apr; 31(3):107531. PubMed ID: 32320652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comprehensive study on the immunological reactivity of the Hsp90 molecular chaperone.
    Kawano T; Kobayakawa T; Fukuma Y; Yukitake H; Kikuchi Y; Shoji M; Nakayama K; Mizuno A; Takagi T; Nemoto TK
    J Biochem; 2004 Nov; 136(5):711-22. PubMed ID: 15632312
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Study on signal transduction pathway in differentiation and apoptosis of leukemia cells induced by heat shock protein inhibitor].
    Yu WJ; Rao Q; Wang M; Tian Z; Xu ZF; Wang JX
    Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):677-80. PubMed ID: 18399173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergistic antipancreatic tumor effect by simultaneously targeting hypoxic cancer cells with HSP90 inhibitor and glycolysis inhibitor.
    Cao X; Bloomston M; Zhang T; Frankel WL; Jia G; Wang B; Hall NC; Koch RM; Cheng H; Knopp MV; Sun D
    Clin Cancer Res; 2008 Mar; 14(6):1831-9. PubMed ID: 18347186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hsp90 cleavage by an oxidative stress leads to its client proteins degradation and cancer cell death.
    Beck R; Verrax J; Gonze T; Zappone M; Pedrosa RC; Taper H; Feron O; Calderon PB
    Biochem Pharmacol; 2009 Feb; 77(3):375-83. PubMed ID: 19014912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Indirect participation of Hsp90 in the regulation of the cyclin E turnover.
    Bedin M; Catelli MG; Cabanié L; Gaben AM; Mester J
    Biochem Pharmacol; 2009 Jan; 77(2):151-8. PubMed ID: 18977205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor selectivity of Hsp90 inhibitors: the explanation remains elusive.
    Chiosis G; Neckers L
    ACS Chem Biol; 2006 Jun; 1(5):279-84. PubMed ID: 17163756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of Hsp90 chaperone [corrected] proteins in human tumor tissue.
    McDowell CL; Bryan Sutton R; Obermann WM
    Int J Biol Macromol; 2009 Oct; 45(3):310-4. PubMed ID: 19576239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the Hsp90 inhibitor NVP-AUY922 in multicellular tumour spheroids with respect to effects on growth and PET tracer uptake.
    Monazzam A; Razifar P; Ide S; Rugaard Jensen M; Josephsson R; Blomqvist C; Langström B; Bergström M
    Nucl Med Biol; 2009 Apr; 36(3):335-42. PubMed ID: 19324279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting focal adhesion kinase with dominant-negative FRNK or Hsp90 inhibitor 17-DMAG suppresses tumor growth and metastasis of SiHa cervical xenografts.
    Schwock J; Dhani N; Cao MP; Zheng J; Clarkson R; Radulovich N; Navab R; Horn LC; Hedley DW
    Cancer Res; 2009 Jun; 69(11):4750-9. PubMed ID: 19458065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Hsp90 molecular chaperone: an open and shut case for treatment.
    Pearl LH; Prodromou C; Workman P
    Biochem J; 2008 Mar; 410(3):439-53. PubMed ID: 18290764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unleashing the full potential of Hsp90 inhibitors as cancer therapeutics through simultaneous inactivation of Hsp90, Grp94, and TRAP1.
    Park HK; Yoon NG; Lee JE; Hu S; Yoon S; Kim SY; Hong JH; Nam D; Chae YC; Park JB; Kang BH
    Exp Mol Med; 2020 Jan; 52(1):79-91. PubMed ID: 31956271
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Heat shock proteins: new target in cytoprotective and tumor therapy].
    Bao XQ; Liu GT
    Yao Xue Xue Bao; 2008 Mar; 43(3):234-40. PubMed ID: 18630257
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction of heat-shock protein 90 beta isoform (HSP90 beta) with cellular inhibitor of apoptosis 1 (c-IAP1) is required for cell differentiation.
    Didelot C; Lanneau D; Brunet M; Bouchot A; Cartier J; Jacquel A; Ducoroy P; Cathelin S; Decologne N; Chiosis G; Dubrez-Daloz L; Solary E; Garrido C
    Cell Death Differ; 2008 May; 15(5):859-66. PubMed ID: 18239673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heat shock protein-90 inhibitors increase MHC class I-related chain A and B ligand expression on multiple myeloma cells and their ability to trigger NK cell degranulation.
    Fionda C; Soriani A; Malgarini G; Iannitto ML; Santoni A; Cippitelli M
    J Immunol; 2009 Oct; 183(7):4385-94. PubMed ID: 19748980
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TRAP1 Chaperones the Metabolic Switch in Cancer.
    Wengert LA; Backe SJ; Bourboulia D; Mollapour M; Woodford MR
    Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene expression profiles of necrosis and apoptosis induced by 5-fluoro-2'-deoxyuridine.
    Sato A; Hiramoto A; Uchikubo Y; Miyazaki E; Satake A; Naito T; Hiraoka O; Miyake T; Kim HS; Wataya Y
    Genomics; 2008 Jul; 92(1):9-17. PubMed ID: 18572099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.